Tag
2 articles
The FDA is launching a pilot program to monitor clinical trials in real time using AI and cloud computing, aiming to speed up drug approvals.
California-based startup Kintsugi is shutting down after failing to secure FDA clearance for its depression-detecting AI, releasing most of its technology as open-source. The company's experience highlights the regulatory challenges facing mental health AI startups.
